Dermata Therapeutics Inc (DRMA)

NASDAQ
1.55
+0.05(+3.33%)
After Hours
1.55
0.00(0.00%)
- Real-time Data
  • Volume:
    135,528
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    1.43 - 1.65

DRMA Overview

Prev. Close
1.5
Day's Range
1.43-1.65
Revenue
-
Open
1.45
52 wk Range
1.41-6.95
EPS
-
Volume
135,528
Market Cap
12.91M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
315,041
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
8,328,629
Next Earnings Date
Mar 02, 2022
What is your sentiment on Dermata Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Dermata Therapeutics Inc Company Profile

Employees
7

Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the treatment of medical and aesthetic skin conditions. The company’s lead product candidate is DMT310, a once-weekly topical product that is under clinical development for the treatment of acne vulgaris, psoriasis vulgaris, and papulopustular rosacea. It is also developing DMT410 for the treatment of hyperhidrosis and aesthetic conditions. The company was founded in 2014 and is headquartered in San Diego, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyStrong BuyStrong SellSell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.